H6H
EGRX

Hightower 6M Holding’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hightower 6M Holding’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$234K Sell
8,862
-253
-3% -$9.28K 0.02% 194
2022
Q2 		$405K Sell
9,115
-29
-0.3% -$1.33K 0.03% 155
2022
Q1 		$453K Buy
+9,144
New +$439K 0.03% 154

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Hightower 6M Holding's EGRX Position: Q3 2022 in Review

Hightower 6M Holding reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 2.8% in Q3 2022, selling an estimated $9.28K and leaving 8,862 shares worth $234K. The position accounts for 0.02% of the portfolio, ranked #194.

Hightower 6M Holding first reported a position in EGRX in Q1 2022 and has held it in 3 quarters since. The position peaked at $453K in Q1 2022. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.

  • Hightower 6M Holding held 8,862 shares of Eagle Pharmaceuticals, Inc. worth $234K as of Q3 2022.
  • Hightower 6M Holding sold 253 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $9.28K.
  • Eagle Pharmaceuticals, Inc. made up 0.02% of Hightower 6M Holding's portfolio in Q3 2022, its #194 holding.
  • Hightower 6M Holding first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2022 and has held it in 3 quarters since.
  • Hightower 6M Holding's Eagle Pharmaceuticals, Inc. position peaked at $453K in Q1 2022.
  • 153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.